医学部クラスター部門

Medicine & Life Sciences

1. Endoscopic Mucosal Resection 100%
2. Mutation 60%
3. Stomach Neoplasms 54%
4. Japan 51%
5. Genes 45%
6. Ulcerative Colitis 45%
7. Neoplasms 43%
8. Esophageal Neoplasms 42%
9. Stomach 38%
10. Therapeutics 37%
11. Esophagectomy 34%
12. Esophageal Squamous Cell Carcinoma 29%
13. Phenotype 28%
14. Endoscopy 27%
15. Sepsis 25%
16. Blood Platelets 24%
17. Drug Therapy 24%
18. Knee 23%
19. Survival 23%
20. Prospective Studies 22%
21. Recurrence 22%
22. Hemorrhage 22%
23. Safety 21%
24. Lung 20%
25. Kidney 20%
26. Crohn Disease 20%
27. Intellectual Disability 19%
28. Non-Small Cell Lung Carcinoma 19%
29. Hematopoietic Stem Cell Transplantation 19%
30. Joints 19%
31. Capsule Endoscopy 19%
32. Inflammatory Bowel Diseases 18%
33. Atrial Fibrillation 18%
34. Serum 18%
35. Confidence Intervals 18%
36. Gastrectomy 16%
37. Acute Lung Injury 16%
38. Renal Dialysis 16%
39. Peritoneal Dialysis 16%
40. CHARGE Syndrome 16%
41. Cohort Studies 16%
42. Multicenter Studies 15%
43. Randomized Controlled Trials 15%
44. Colonoscopy 15%
45. Fibrinogen 14%
46. Inflammation 14%
47. Colitis 14%
48. Bone and Bones 14%
49. Aged, 80 and over 14%
50. Proteins 14%
51. Wounds and Injuries 14%
52. Oryzias 14%
53. Elderly 14%
54. Exons 14%
55. Neoplasm Metastasis 13%
56. Adult Respiratory Distress Syndrome 13%
57. Lung Neoplasms 13%
58. Kampo Medicine 13%
59. Lymph Nodes 13%
60. Nivolumab 13%
61. Adenocarcinoma 12%
62. Odds Ratio 12%
63. Infections 12%
64. Exome 12%
65. Ligaments 12%
66. T-Lymphocytes 12%
67. Alendronate 12%
68. Breast Neoplasms 12%
69. Colon 12%
70. Knee Replacement Arthroplasties 11%
71. Colorectal Neoplasms 11%
72. Incidence 11%
73. Retrospective Studies 11%
74. Quality of Life 11%
75. Gastrointestinal Endoscopy 11%
76. Tomography 11%
77. Catheter Ablation 11%
78. Capsule Endoscopes 11%
79. Mortality 10%
80. Exercise 10%
81. Skin 10%
82. Biopsy 10%
83. Alleles 10%
84. Biomarkers 10%
85. Population 10%
86. Chemoradiotherapy 10%
87. Antibodies 10%
88. Induced Pluripotent Stem Cells 10%
89. Pancreatic Neoplasms 10%
90. Meta-Analysis 10%
91. Mucous Membrane 10%
92. Adenoma 10%
93. Surgical Instruments 10%
94. Observational Studies 10%
95. Carcinoma 9%
96. Swine 9%
97. Cisplatin 9%
98. Elbow 9%
99. Messenger RNA 9%
100. Pneumonia 9%